Population aging presents a growing societal challenge and imposes a heavy burden on the healthcare system in many Asian countries. Given the limited availability of formal long-term care (LTC) facilities and personnel, family caregivers play a vital role in providing care for the increasing population of older adults. While awareness of the challenges faced by caregivers is rising, discussions often remain within academic circles, resulting in the lived experiences, well-being, and needs of family caregivers being frequently overlooked. In this review, we identify four key priority areas to advance research, practice, and policy related to family caregivers in Asia: (1) Emphasizing family caregivers as sociocultural navigators in the healthcare system; (2) addressing the mental and physical health needs of family caregivers; (3) recognizing the diverse caregiving experiences across different cultural backgrounds, socioeconomic status, and countries of residence; and (4) strengthening policy support for family caregivers. Our review also identifies deficiencies in institutional LTC and underscores the importance of providing training and empowerment to caregivers. Policymakers, practitioners, and researchers interested in supporting family caregivers should prioritize these key areas to tackle the challenge of population aging in Asian countries. Cross-country knowledge exchange and capacity development are crucial for better serving both the aging population and their caregivers.
{"title":"Caregiving in Asia: Priority areas for research, policy, and practice to support family caregivers","authors":"Nan Jiang, Bei Wu, Yan Li","doi":"10.1002/hcs2.124","DOIUrl":"10.1002/hcs2.124","url":null,"abstract":"<p>Population aging presents a growing societal challenge and imposes a heavy burden on the healthcare system in many Asian countries. Given the limited availability of formal long-term care (LTC) facilities and personnel, family caregivers play a vital role in providing care for the increasing population of older adults. While awareness of the challenges faced by caregivers is rising, discussions often remain within academic circles, resulting in the lived experiences, well-being, and needs of family caregivers being frequently overlooked. In this review, we identify four key priority areas to advance research, practice, and policy related to family caregivers in Asia: (1) Emphasizing family caregivers as sociocultural navigators in the healthcare system; (2) addressing the mental and physical health needs of family caregivers; (3) recognizing the diverse caregiving experiences across different cultural backgrounds, socioeconomic status, and countries of residence; and (4) strengthening policy support for family caregivers. Our review also identifies deficiencies in institutional LTC and underscores the importance of providing training and empowerment to caregivers. Policymakers, practitioners, and researchers interested in supporting family caregivers should prioritize these key areas to tackle the challenge of population aging in Asian countries. Cross-country knowledge exchange and capacity development are crucial for better serving both the aging population and their caregivers.</p>","PeriodicalId":100601,"journal":{"name":"Health Care Science","volume":"3 6","pages":"374-382"},"PeriodicalIF":0.0,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11671212/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142904704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The COVID-19 pandemic presented unparalleled challenges to prompt and adaptive responses from nations worldwide. This review examines China's multifaceted approach to the crisis, focusing on five key areas of response: infrastructure and system design, medical care and treatment, disease prevention and control, economic and social resilience, and China's engagement in global health. This review demonstrates the effectiveness of a top-down command system at the national level, intersectoral coordination, a legal framework, and public social governance. This study also examines medical care and treatment strategies, highlighting the importance of rapid emergency response, evidence-based treatment, and well-planned vaccination rollout. Further discussion on disease prevention and control measures emphasizes the importance of adaptive measures, timely infection control, transmission interruption, population herd immunity, and technology applications. Socioeconomic impact was also assessed, detailing strategies for disease prevention, material supply, livelihood preservation, and social economy revival. Lastly, we examine China's contributions to the global health community, with a focus on knowledge-sharing, information exchange, and multilateral assistance. While it is true that each nation's response must be tailored to its own context, there are universal lessons to be drawn from China's approach. These insights are pivotal for enhancing global health security, especially as the world navigates evolving health crises.
{"title":"Innovative public strategies in response to COVID-19: A review of practices from China","authors":"You Wu, Zijian Cao, Jing Yang, Xinran Bi, Weiqing Xiong, Xiaoru Feng, Yue Yan, Zeyu Zhang, Zongjiu Zhang","doi":"10.1002/hcs2.122","DOIUrl":"10.1002/hcs2.122","url":null,"abstract":"<p>The COVID-19 pandemic presented unparalleled challenges to prompt and adaptive responses from nations worldwide. This review examines China's multifaceted approach to the crisis, focusing on five key areas of response: infrastructure and system design, medical care and treatment, disease prevention and control, economic and social resilience, and China's engagement in global health. This review demonstrates the effectiveness of a top-down command system at the national level, intersectoral coordination, a legal framework, and public social governance. This study also examines medical care and treatment strategies, highlighting the importance of rapid emergency response, evidence-based treatment, and well-planned vaccination rollout. Further discussion on disease prevention and control measures emphasizes the importance of adaptive measures, timely infection control, transmission interruption, population herd immunity, and technology applications. Socioeconomic impact was also assessed, detailing strategies for disease prevention, material supply, livelihood preservation, and social economy revival. Lastly, we examine China's contributions to the global health community, with a focus on knowledge-sharing, information exchange, and multilateral assistance. While it is true that each nation's response must be tailored to its own context, there are universal lessons to be drawn from China's approach. These insights are pivotal for enhancing global health security, especially as the world navigates evolving health crises.</p>","PeriodicalId":100601,"journal":{"name":"Health Care Science","volume":"3 6","pages":"383-408"},"PeriodicalIF":0.0,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11671218/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142904714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Haihong Zhang, You Wu, Haibo Wang, Weili Zhao, Yali Cong
<p>On October 19, 2024, the 75th General Assembly of the World Medical Association (WMA) in Finland adopted the latest version of the Declaration of Helsinki (DoH)—Ethical Principles for Medical Research Involving Human Participants [<span>1</span>] (hereafter referred to as “the Declaration”). This revision process took 30 months, with the working group comprising representatives from medical associations in 19 countries and regions. From April 2022 to September 2024, the working group held eight regional expert meetings and two times global consultations, gathering suggestions from both experts and the general public [<span>2</span>]. Besides, the working group developed regular online meeting working mechanisms.</p><p>Basically, the general ethical principles for respecting and protecting human participants are stable over time, while more tailored interpretations and justifications should be adapted in a timely manner. The revision focused on alignment with wide-accepted ethical guidelines at the international level, emphasizing coherence with other related documents within, and beyond the WMA. The Declaration emphasises the overarching principles and does not delve into many specifics; however, its core principles remain universally applicable.</p><p>While these revisions represent significant progress, some also reflect substantial compromises. Notably, to strengthen the protection of research participants’ rights and well-being, the Declaration reaffirms that “<i>These purposes can never take precedence over the rights and interests of individual research participants</i>” and requires all stakeholders, including individuals, teams, and organizations involved in medical research to adhere to ethical principles that respect for and protect of research participants [<span>7</span>]. Given the WMA's mandate as a global organization of physicians, the term “<i>medical research</i>” was retained rather than adopting broader terminology such as “health-related research.” However, the document refers to “<i>physicians</i>,” or “<i>physicians and other researchers</i>” in constituent paragraphs, acknowledging both the critical role of physicians in medical practices and the specialized division of roles in research involving human participants. Compared to the 2013 version, the new Declaration strengthens researchers' responsibilities and protections for research participants (e.g., Articles 9, 10, 12, 17, 21, 23, 32, and 34), increasing the instances of the word “must” from 46 to 58 and clarifying the distinction between “<i>should</i>” and “<i>must</i>.”</p><p>Renaming “<i>subjects</i>” as “<i>participants</i>” not only mandates respect for participants' rights and agency but also calls for a partnership between researchers and participants. Developing such partnership requires that physicians/researchers strictly fulfill their duties, with the best interests of patients, including those participating in research, as the priority, promoting and
{"title":"Sixty years of ethical evolution: The 2024 revision of the Declaration of Helsinki (DoH)","authors":"Haihong Zhang, You Wu, Haibo Wang, Weili Zhao, Yali Cong","doi":"10.1002/hcs2.126","DOIUrl":"10.1002/hcs2.126","url":null,"abstract":"<p>On October 19, 2024, the 75th General Assembly of the World Medical Association (WMA) in Finland adopted the latest version of the Declaration of Helsinki (DoH)—Ethical Principles for Medical Research Involving Human Participants [<span>1</span>] (hereafter referred to as “the Declaration”). This revision process took 30 months, with the working group comprising representatives from medical associations in 19 countries and regions. From April 2022 to September 2024, the working group held eight regional expert meetings and two times global consultations, gathering suggestions from both experts and the general public [<span>2</span>]. Besides, the working group developed regular online meeting working mechanisms.</p><p>Basically, the general ethical principles for respecting and protecting human participants are stable over time, while more tailored interpretations and justifications should be adapted in a timely manner. The revision focused on alignment with wide-accepted ethical guidelines at the international level, emphasizing coherence with other related documents within, and beyond the WMA. The Declaration emphasises the overarching principles and does not delve into many specifics; however, its core principles remain universally applicable.</p><p>While these revisions represent significant progress, some also reflect substantial compromises. Notably, to strengthen the protection of research participants’ rights and well-being, the Declaration reaffirms that “<i>These purposes can never take precedence over the rights and interests of individual research participants</i>” and requires all stakeholders, including individuals, teams, and organizations involved in medical research to adhere to ethical principles that respect for and protect of research participants [<span>7</span>]. Given the WMA's mandate as a global organization of physicians, the term “<i>medical research</i>” was retained rather than adopting broader terminology such as “health-related research.” However, the document refers to “<i>physicians</i>,” or “<i>physicians and other researchers</i>” in constituent paragraphs, acknowledging both the critical role of physicians in medical practices and the specialized division of roles in research involving human participants. Compared to the 2013 version, the new Declaration strengthens researchers' responsibilities and protections for research participants (e.g., Articles 9, 10, 12, 17, 21, 23, 32, and 34), increasing the instances of the word “must” from 46 to 58 and clarifying the distinction between “<i>should</i>” and “<i>must</i>.”</p><p>Renaming “<i>subjects</i>” as “<i>participants</i>” not only mandates respect for participants' rights and agency but also calls for a partnership between researchers and participants. Developing such partnership requires that physicians/researchers strictly fulfill their duties, with the best interests of patients, including those participating in research, as the priority, promoting and ","PeriodicalId":100601,"journal":{"name":"Health Care Science","volume":"3 6","pages":"371-373"},"PeriodicalIF":0.0,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11671210/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142904672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}